NEW YORK – Oxford Immunotec said on Wednesday it has begun a collaboration with specialty vaccine firm Valneva to perform T-cell testing on participants receiving Valneva's COVID-19 vaccine candidate in a study.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.